Evoke Pharma
EVOK
#10180
Rank
$18.82 M
Marketcap
$10.93
Share price
-0.09%
Change (1 day)
159.00%
Change (1 year)

P/S ratio for Evoke Pharma (EVOK)

P/S ratio as of December 2025 (TTM): 1.47

According to Evoke Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.30. At the end of 2025 the company had a P/S ratio of 0.3065.

P/S ratio history for Evoke Pharma from 2013 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20250.3065-56.5%
20240.70463.96%
20230.6778-81.02%
20223.57-67.83%
202111.1-99.62%
2020> 1000
2019N/A
2018N/A
2017N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Ironwood Pharmaceuticals
IRWD
1.67 13.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
2.22 50.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amphastar Pharmaceuticals
AMPH
1.73 17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
3.52 139.37%๐Ÿ‡บ๐Ÿ‡ธ USA